Soluble adhesion molecules in Finnish schoolchildren with signs of preclinical type 1 diabetes
Authors:
- 16 January 2004
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 20 (1) , 48-54
Abstract
Background: We measured the circulating concentrations of the soluble forms of intercellular adhesion molecule‐1, ICAM‐1 (sCD54) and L‐selectin (sCD62L) in 104 non‐diabetic Finnish schoolchildren testing positive for one or more diabetes‐associated autoantibodies and in 104 autoantibody‐negative children to elucidate the relationship between soluble adhesion molecules and humoral, genetic and metabolic markers of preclinical type 1 diabetes.Methods: Specific enzyme‐linked immunosorbent assays were used to analyse serum sICAM‐1 and sL‐selectin concentrations.Results: The sICAM‐1 and sL‐selectin levels were comparable in the autoantibody‐positive and control children, even when comparing children with multiple autoantibodies with those having one or no autoantibodies. The IA‐2A titres in children testing positive for this autoantibody correlated with the sICAM‐1 concentrations (rs = 0.62, P = 0.05), but otherwise no significant associations were seen between the autoantibody specificities and the concentrations of soluble adhesion molecules. Control children with HLA DQB1 genotypes conferring a low or decreased risk of type 1 diabetes had higher levels of sL‐selectin than those with high or moderate risk genotypes (P = 0.04). sL‐selectin concentrations were significantly increased in the autoantibody‐positive children with a first‐phase insulin response (FPIR) below the 5th (n = 11;P = 0.026) or 10th percentiles (n = 17;P = 0.009) relative to the children with a normal FPIR. No associations were observed between sICAM‐1 concentrations and DQB1 genotypes or FPIR.Conclusions: The data indicate that there are a few conspicuous signs of endothelial/leukocyte activation reflected in increased circulating levels of soluble adhesion molecules in schoolchildren who are positive for markers of preclinical type 1 diabetes. The correlation between sICAM‐1 concentrations and IA‐2A levels in the IA‐2A‐positive children suggests that the former may increase in late preclinical type 1 diabetes, as IA‐2A are the last autoantibodies to appear in the prediabetic process. Increased sL‐selectin concentrations in subjects with impaired β‐cell function may reflect an active destructive insulitis process. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 34 references indexed in Scilit:
- The First Signs of -Cell Autoimmunity Appear in Infancy in Genetically Susceptible Children from the General Population: The Finnish Type 1 Diabetes Prediction and Prevention StudyThe Journal of Clinical Endocrinology & Metabolism, 2001
- Soluble L‐selectin levels in type I diabetes mellitus: a surrogate marker fordisease activity?Immunology, 2000
- Prediction of Diabetes in Biobreeding/Aburahi Rats by the Measurement of Soluble L-SelectinAutoimmunity, 2000
- Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group.Journal of Clinical Investigation, 1998
- HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group.Journal of Clinical Investigation, 1996
- Rapid HLA-DQB1 Genotyping for Four Alleles in the Assessment of Risk for IDDM in the Finnish PopulationDiabetes Care, 1996
- Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study GroupThe Journal of Clinical Endocrinology & Metabolism, 1996
- Circulating adhesion molecules in diseaseImmunology Today, 1993
- Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1992
- Adhesion receptors of the immune systemNature, 1990